Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Balchem Corporation (NASDAQ: BCPC) reported record second quarter net earnings of $22.7 million for 2021, a 7.6% increase from $21.1 million in Q2 2020. Adjusted net earnings rose to $30.4 million, up 10.3%. Net sales reached $202.4 million, a 16.7% increase driven by growth in all segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Despite experiencing a $3.8 million loss from a flash flood event, cash flows remained strong with $35.8 million from operations. The effective tax rate increased to 24.3% from 18.7% in the prior year.
Balchem Corporation (NASDAQ: BCPC) is set to present at the Jefferies Virtual Industrials Conference on August 4, 2021, starting at 9:00 a.m. ET. The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Investors and interested parties can listen to the presentation via the provided link.
Balchem specializes in developing, manufacturing, and marketing ingredients aimed at improving health across various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on July 30, 2021, at 11:00 AM ET to discuss its second quarter results. The results will be published before the market opens on the same day. The conference call, hosted by Ted Harris (CEO) and Martin Bengtsson (CFO), will be available for replay until August 13, 2021. Interested parties can access the call by dialing toll-free 1-877-407-8289. More details including financial exhibits will be available on balchem.com.
Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021, starting at 9:00 a.m. (ET). Chairman and CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Investors can follow the link to listen live: Presentation Link.
Balchem develops specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, enhancing health and well-being globally.
Balchem Corporation (NASDAQ: BCPC) reported strong first-quarter 2021 financial results, achieving net earnings of $23.4 million, up 18.4% year-over-year. Adjusted net earnings also rose to $28.4 million, reflecting growth across all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Net sales increased by 6.4% to $185.7 million, with notable contributions from chelated minerals and choline nutrients. The company maintained strong cash flow, leading to $40.6 million in operational cash flow and $34.4 million in free cash flow.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for April 30, 2021, at 11:00 AM ET to discuss its first quarter results. The financial results will be released before the market opens on the same day. Attendees can join the call by dialing a toll-free number and access a replay through specified numbers until May 14, 2021. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being.
Balchem Corporation (NASDAQ: BCPC) will present at the J.P. Morgan Industrials Conference on March 15, 2021. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation, starting at 9:40 a.m. ET. Interested parties can follow the provided link to listen live.
Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries. Their operations are divided into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported fourth quarter 2020 net earnings of $22.2 million, a rise from $20.4 million in Q4 2019. Adjusted net earnings decreased to $26.9 million from $28.4 million. Record quarterly net sales reached $180.7 million, an increase of 8.5% year-over-year. Full-year net earnings were $84.6 million, with adjusted net earnings at $107.8 million. Strong cash flow supported debt repayments totaling $30 million in Q4 and $95 million for the year, lowering net debt to $79 million.
Balchem Corporation (NASDAQ: BCPC) will feature a presentation by Chairman and CEO Ted Harris and CFO Martin Bengtsson during a H.C. Wainwright Fireside Chat on February 24, 2021, starting at 2:00 p.m. (EDT). This event aims to showcase Balchem’s innovative solutions in the health and nutrition sectors.
Balchem develops and markets specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being globally.